Ducommun (DCO) Cash & Equivalents (2010 - 2026)

Ducommun has reported Cash & Equivalents for 17 years, with the latest figure at $39.1 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 27.24% year-over-year to $39.1 million; the trailing twelve-month figure through Apr 2026 stood at $39.1 million (up 27.24% YoY), and the FY2025 full-year result was $45.3 million, up 21.94% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $39.1 million, down from $45.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $50.9 million in Q3 2025, with the low at $17.1 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $33.7 million across 5 years, with a median of $37.1 million in 2025.
• The largest YoY upside for Cash & Equivalents was 212.61% in 2022 against a maximum downside of 39.4% in 2022.
• Ducommun's Cash & Equivalents stood at $46.2 million in 2022, then retreated by 7.32% to $42.9 million in 2023, then decreased by 13.35% to $37.1 million in 2024, then increased by 21.94% to $45.3 million in 2025, then retreated by 13.66% to $39.1 million in 2026.
• The last three Cash & Equivalents figures came in at $39.1 million (Q2 2026), $45.3 million (Q4 2025), and $50.9 million (Q3 2025), per Business Quant data.